Pulmonary Arteriovenous Malformations

Respiratory
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Okami Medical
Okami MedicalCA - Aliso Viejo
1 program
PAVM EmbolizationN/A1 trial
Active Trials
NCT06735976Recruiting30Est. Dec 2029

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
Okami MedicalPAVM Embolization

Clinical Trials (1)

Total enrollment: 30 patients across 1 trials

NCT06735976Okami MedicalPAVM Embolization

Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations

Start: Dec 2024Est. completion: Dec 202930 patients
N/ARecruiting

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 30 patients
1 companies competing in this space